Crystax Pharmaceuticals is a leading structure-based drug discovery company. Crystax identifies and develops new lead compounds by a combination of structural and biophysical techniques that accelerate the process of drug discovery and bring higher quality molecules to the market. Core areas of expertise are: X-ray Crystallography, NMR, Fragment Screening and Hit Optimization by biophysical analysis and computational chemistry.